Protocatechuic Acid Inhibits Lung Cancer Cells by Modulating FAK, MAPK, and NF-κB Pathways

REFERENCES

• Chen CJ, You SL, Lin H, Hsu WL, and Yang YW: Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 32, 66–81, 2002.
   PubMed Web of Science ®Google Scholar
• Walker S: Updates in non-small cell lung cancer. Clin J Oncol Nurs 12, 587–596, 2008.
   PubMed Web of Science ®Google Scholar
• Pasqualetti G, Ricciardi S, Mey V, Del Tacca M, and Danesi R: Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines. Lung Cancer 74, 197–205, 2011.
   PubMed Web of Science ®Google Scholar
• Huang CY, Lin CY, Tsai CW, and Yin MC: Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol In Vitro 25, 1274–1280, 2011.
   PubMed Web of Science ®Google Scholar
• Masella R, Santangelo C, D’Archivio M, Volti G, Giovannini C, et al.: Protocatechuic acid and human disease prevention: biological activities and molecular mechanisms. Curr Med Chem 19, 2901–2917, 2012.
   PubMed Web of Science ®Google Scholar
• Azzini E, Vitaglione P, Intorre F, Napolitano A, Durazzo A, et al.: Bioavailability of strawberry antioxidants in human subjects. Br J Nutr 104, 1165–1173, 2010.
   PubMed Web of Science ®Google Scholar
• Koli R, Erlund I, Jula A, Marniemi J, Mattila P, et al.: Bioavailability of various polyphenols from a diet containing moderate amounts of berries. J Agric Food Chem 58, 3927–3932, 2010.
   PubMed Web of Science ®Google Scholar
• Yin MC, Lin CC, Wu HC, Tsao SM, and Hsu CK: Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. J Agric Food Chem 57, 6468–6473, 2009.
   PubMed Web of Science ®Google Scholar
• Leung HW, Yang WH, Lai MY, Lin CJ, and Lee HZ: Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 45, 403–411, 2007.
   PubMed Web of Science ®Google Scholar
• Lúcio KA, Rocha G, Monção-Ribeiro LC, Fernandes J, Takiya CM, et al.: Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo. PLoS One 6, e28596, 2011.
   PubMed Web of Science ®Google Scholar
• Han S, Ritzenthaler JD, Sitaraman SV, and Roman J: Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281, 29614–29624, 2006.
   PubMed Web of Science ®Google Scholar
• Park JK, Park SH, So K, Bae IH, Yoo YD, et al.: ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol 36, 181–192, 2010.
   PubMed Web of Science ®Google Scholar
• Dowlati A, Gray R, Sandler AB, Schiller JH, and Johnson DH: Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab-an Eastern Cooperative Oncology Group Study. Clin Cancer Res 14, 1407–1412, 2008.
   PubMed Web of Science ®Google Scholar
• Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, et al.: Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501. J Clin Oncol 27, 6006–6011, 2009.
   PubMed Web of Science ®Google Scholar
• Alam M, Wang JH, Coffey JC, Qadri SS, O’Donnell A, et al.: Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines. Ann Surg Oncol 14, 2678–2684, 2007.
   PubMed Web of Science ®Google Scholar
• Zhao J, Harper R, Barchowsky A, and Di YP: Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 293, 480–490, 2007.
   Web of Science ®Google Scholar
• Shieh JM, Cheng TH, Shi MD, Wu PF, Chen Y, et al.: α-Tomatine suppresses invasion and migration of human non-small cell lung cancer NCI-H460 cells through inactivating FAK/PI3K/Akt signaling pathway and reducing binding activity of NF-κB. Cell Biochem Biophys 60, 297–310, 2011.
   PubMed Web of Science ®Google Scholar
• Kausar H, Jeyabalan J, Aqil F, Chabba D, Sidana J, et al.: Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Lett 325, 54–62, 2012.
   PubMed Web of Science ®Google Scholar
• Torlinska T, and Grochowalska A: Age-related changes of Na+, K+-ATPase, Ca2+-ATPase and Mg2+-ATPase activities in rat brain synaptosomes. J Physiol Pharmacol 55, 457–465, 2004.
   PubMed Web of Science ®Google Scholar
• Yin W, Cheng W, Shen W, Shu L, Zhao J, et al.: Impairment of Na(+),K(+)-ATPase in CD95(APO-1)-induced human T-cell leukemia cell apoptosis mediated by glutathione depletion and generation of hydrogen peroxide. Leukemia 21, 1669–1678, 2007.
   PubMed Web of Science ®Google Scholar
• Einbond LS, Shimizu M, Ma H, Wu HA, Goldsberry S, et al.: Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem Biophys Res Commun 375, 608–613, 2008.
   PubMed Web of Science ®Google Scholar
• Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, et al.: Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate 67, 582–590, 2007.
   PubMed Web of Science ®Google Scholar
• Kim R, Emi M, Tanabe K, Murakami S, Uchida Y, et al.: Regulation and interplay of apoptotic and non-apoptotic cell death. J Pathol 208, 319–326, 2006.
   PubMed Web of Science ®Google Scholar
• Shou Y, Hirano T, Gong Y, Kato Y, Yoshida K, et al.: Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer. Br J Cancer 85, 1706–1712, 2001.
   PubMed Web of Science ®Google Scholar
• Ritzenthaler JD, Han S, and Roman J: Stimulation of lung carcinoma cell growth by fibronectin-integrin signaling. Mol Biosyst 4, 1160–1169, 2008.
   PubMed Web of Science ®Google Scholar
• Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, et al.: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3, 589–601, 2003.
   PubMed Web of Science ®Google Scholar
• Liu G, Meng X, Jin Y, Bai J, Zhao Y, et al.: Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell Biol Int 32, 663–670, 2008.
   PubMed Web of Science ®Google Scholar
• Shih YW, Chien ST, Chen PS, Lee JH, Wu SH, et al.: Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem Biophys 58, 31–44, 2010.
   PubMed Web of Science ®Google Scholar
• Siejka A, Barabutis N, and Schally AV: GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro. Peptides 37, 63–68, 2012.
   PubMed Web of Science ®Google Scholar
• Yang HT, Chao PC, and Yin MC: Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration. J Food Sci 78, 343–349, 2013.
   PubMed Web of Science ®Google Scholar
• Lemmon CR, Woo JH, Tully E, Wilsbach K, and Gabrielson E: Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase. J Biol Chem 286, 3157–3165, 2011.
   Web of Science ®Google Scholar
• Germano G, Mantovani A, and Allavena P: Targeting of the innate immunity/inflammation as complementary anti-tumor therapies. Ann Med 43, 581–593, 2011.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Kohno H, Sugie S, and Tanaka T: Dietary protocatechuic acid during the progression phase exerts chemopreventive effects on chemically induced rat tongue carcinogenesis. Asian Pac J Cancer Prev 4, 319–326, 2003.
   PubMedGoogle Scholar